ALLMedicine™ Acute Intermittent Porphyria Center
Research & Reviews 361 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913433
Orphanet Journal of Rare Diseases; Buendía-Martínez J, Barreda-Sánchez M et. al.
Feb 28th, 2021 - Acute intermittent porphyria (AIP) is a genetic disease characterized by acute neurovisceral attacks. Long-term clinical conditions, chronic symptoms and impaired health related quality of life (HRQoL) have been reported during non-attack periods ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809922
The Journal of International Medical Research; Huang S, Li R et. al.
Jan 12th, 2021 - Acute intermittent porphyria (AIP) is a rare autosomal dominant metabolic disease with a broad spectrum of clinical manifestations, and can be easily confused with other diseases. Many patients with porphyria may have symptoms of peripheral nerve ...
https://doi.org/10.1002/lt.25979
Liver Transplantation : Official Publication of the Ameri... Moghe A, Anderson KE
Dec 28th, 2020 - Expanding Experience With Liver Transplantation in Acute Intermittent Porphyria.|2020|Moghe A,Anderson KE,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727547
Hematology. American Society of Hematology. Education Pro... Linenberger M, Fertrin KY
Dec 4th, 2020 - The porphyrias are a family of metabolic disorders caused by defects in the activity of one of the enzymes in the heme biosynthetic pathway. Acute intermittent porphyria (AIP), caused by autosomal dominant mutations in the gene encoding hydroxymet...
https://doi.org/10.1002/lt.25959
Liver Transplantation : Official Publication of the Ameri... Lissing M, Nowak G et. al.
Dec 1st, 2020 - Recurrent attacks of acute intermittent porphyria (AIP) result in poor quality of life and significant risks of morbidity and mortality. Liver transplantation (LT) offers a cure, but published data on outcomes after LT are limited. We assessed the...
Guidelines 1 results
https://doi.org/10.1177/0004563212474555
Annals of Clinical Biochemistry; Stein P, Badminton M et. al.
Apr 22nd, 2013 - The British and Irish Porphyria Network guidelines describe best practice in the clinical assessment, investigation and management of acute porphyria attacks and their complications, including severe attacks with neuropathy. Acute attacks of porph...
Drugs 67 results see all →
Clinicaltrials.gov 437 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9984267a-4d57-4444-9bb5-16bca7dea691
Apr 1st, 2021 - PANHEMATIN is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after initial carbohydrate therapy is known or suspected to be ...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d58570a0-58b0-4662-b2ad-aa8d1463b4c1
Mar 28th, 2021 - For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the tre...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6065ac5-a111-449b-b51b-8bc2907d1ddb
Mar 23rd, 2021 - For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the tre...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b8545ef-312d-4af6-a082-2497b84ff161
Feb 28th, 2021 - For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the tre...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5bfe1700-9216-4ba3-bd9d-d0ea72735bdc
Feb 28th, 2021 - For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the tre...
News 9 results
https://www.mdedge.com/familymedicine/article/211805/dermatology/chronic-blistering-rash-hands/page/0/2?channel=203
MDedge Family Medicine;
Nov 7th, 2019 - Pseudoporphyria has a similar presentation to PCT but with no abnormalities in porphyrin metabolism. Risk factors include UV radiation exposure; use of medications such as nonsteroidal anti-inflammatory drugs, diuretics, and retinoids; chronic ren.
https://www.mdedge.com/internalmedicine/article/199737/hepatology/video-givosiran-cuts-acute-intermittent-porphyria-attacks/page/0/1?channel=39313
Apr 28th, 2019 - The study’s primary endpoint was the average annualized rate of porphyria attacks during 6 months of treatment, which was 3. 2 attacks in 46 patients evaluable for efficacy on givosiran treatment and 12.
https://www.medscape.com/viewarticle/889629
Dec 5th, 2017 - NEW YORK (Reuters Health) - Abdominal pain and hyponatremia in a 16-year-old girl with constipation and disordered eating confounded the diagnosis of a much less common condition, acute intermittent porphyria (AIP), according to a case report publ...
https://www.mdedge.com/emergencymedicine/article/107206/hematology/case-report-acute-intermittent-porphyria/page/0/1
Mar 1st, 2016 - Treatment Treatment targets runaway heme precursor synthesis at its start and finish (Figure). Glucose-loading suppresses the initial enzyme, ALA synthase.